PureTech Health plc (LON:PRTC – Get Free Report) crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of GBX 126.64 and traded as low as GBX 125.20. PureTech Health shares last traded at GBX 126.20, with a volume of 360,270 shares traded.
PureTech Health Stock Performance
The business has a 50 day moving average of GBX 126.64 and a 200 day moving average of GBX 126.24. The company has a market capitalization of £307.19 million, a P/E ratio of -2.74 and a beta of 0.79. The company has a quick ratio of 2.51, a current ratio of 6.59 and a debt-to-equity ratio of 6.33.
PureTech Health Company Profile
PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule. It is also developing technology and products for screening, diagnosis, and treatment of neurological disorders, such as ADHD, autism, and depression through computer software; noninvasive neurostimulation treatment for psychiatric disorders; and combination therapy for schizophrenia.
Read More
- Five stocks we like better than PureTech Health
- These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?
- 3 Stocks Under $20 to Buy Before a Broader Market Rally
- Petco Faces Tough Competition, But Momentum Is Building
- The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
